Strides Pharma

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

At Strides, we are committed to discovering and developing better and affordable medicine to improve the quality of life for patients worldwide.

To be the leading provider of affordable healthcare solutions and products to patients across the world.

Strides has won several awards globally, including the prestigious Frost & Sullivan ‘ Pharmaceutical Company of the Year’ and ‘Innovation Product of the Year’ for its product, Grastim in 2016. Most recently, the company won the ‘Best Pharma Company in India’ at the 2017 Asia-Pacific International Business Award.